|
Market Closed -
Nasdaq
06:00:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 7.390 USD | -1.60% |
|
-2.89% | +85.68% |
| Market Cap | 111M 98.38M 91.82M 83.69M 158M 10.64B 159M 1.11B 431M 5.44B 416M 407M 17.46B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 109M 97.26M 90.77M 82.74M 156M 10.52B 157M 1.1B 426M 5.38B 411M 402M 17.26B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -1.60% | ||
| 1 week | -2.89% | ||
| Current month | -5.62% | ||
| 1 month | +8.84% | ||
| 3 months | +16.01% | ||
| 6 months | +133.12% | ||
| Current year | +85.68% |
| 1 week | 7.26 |  | 8.14 |
| 1 month | 6.24 | | 8.35 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
Gordon Bernard
BRD | Director/Board Member | 74 | 10/09/2010 |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/3/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/3/26 | Free | Director | 5,800 | 0.0388% | ||
| 18/3/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.60% | -2.89% | +136.10% | +295.19% | 111M | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| +0.94% | -1.46% | +21.43% | +41.95% | 333B | |
| +0.97% | -3.10% | +11.19% | +34.86% | 267B | |
| +0.29% | -4.59% | -6.35% | +9.32% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.31% | -3.48% | +37.21% | +82.57% | 369.73B | |
| Weighted average by Cap. | -0.20% | -3.54% | +29.19% | +70.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.65M 31.4M 28.62M 53.98M 3.64B 54.48M 380M 147M 1.86B 142M 139M 5.97B | 44.52M 39.56M 36.92M 33.65M 63.47M 4.28B 64.06M 447M 173M 2.19B 167M 164M 7.02B |
| Net income | -6.48M -5.76M -5.37M -4.9M -9.24M -623M -9.32M -65.03M -25.2M -318M -24.33M -23.8M -1.02B | -2.84M -2.52M -2.35M -2.14M -4.04M -273M -4.08M -28.46M -11.03M -139M -10.65M -10.42M -447M |
| Net Debt | 2.61M 2.32M 2.16M 1.97M 3.72M 251M 3.75M 26.18M 10.14M 128M 9.79M 9.58M 411M | -1.26M -1.12M -1.05M -956K -1.8M -122M -1.82M -12.69M -4.92M -62.13M -4.75M -4.64M -199M |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | USD 7.390 | -1.60% | 22,629 |
| 01/10/26 | USD 7.510 | -4.09% | 73,339 |
| 30/09/26 | USD 7.830 | +2.35% | 9,962 |
| 29/09/26 | USD 7.650 | -0.91% | 8,930 |
| 28/09/26 | USD 7.720 | +1.45% | 30,313 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
